Advisor Net Financial, Inc Hoth Therapeutics, Inc. Transaction History

Advisor Net Financial, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	SELL	$2.96 - $10.72 $497 - $1,800	-168 Reduced 96.0%	7 $0
Q1 2022 Apr 14, 2022	SELL	$0.52 - $1.3 $91 - $227	-175 Reduced 50.0%	175 $0
Q3 2020 Nov 06, 2020	BUY	$1.86 - $3.15 $651 - $1,102	350 New	350 $1,000

Ticker HOTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,288,470
Market Cap $1.08M
Description
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.